Co-authored journal articles – collaborations and consulting

Selected publications:

• Chatterjee, M., …, M. Schmid, …, A. Schneider (2024): Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALS. Nature Medicine 30 (6), 1771-1783.
• Soch, J., …, M. Schmid, …, B. H. Schott (2024): Single-value brain activity scores reflect both severity and risk across the Alzheimer‘s continuum. Brain, in press.
• Vogelgsang, J., …, M. Schmid, …, J. Wiltfang (2024): Plasma amyloid-beta X-42/X-40 ratio and cognitive decline in suspected early and preclinical Alzheimer’s disease. Alzheimer’s & Dementia, in press.
• Steinbrenner, I., …, M. Schmid, …, P. Sekula (2024): Associations of urine and plasma metabolites with kidney failure and death in a CKD cohort. American Journal of Kidney Diseases, in press.
• Baumeister, H., …, M. Schmid, …, D. Berron (2024): A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings. Brain 147 (7), 2400-2413.
• Hayek, D., …, M. Schmid, …, A. Maass (2024): Different inflammatory signatures based on CSF biomarkers relate to preserved or diminished brain structure and cognition. Molecular Psychiatry 29, 992-1004.
• Faber, J., …, M. Schmid, T. Klockgether (2024): Stage-dependent biomarker changes in spinocerebellar ataxia type 3. Annals of Neurology 95 (2), 400-406.
• Christ, P., …, M. Schmid, B. Sachs (2024): Identification and comparison of sex-specific serious adverse drug reactions in spontaneous reports and systematically collected reports (ADRED). British Journal of Clinical Pharmacology 90 (3), 776-792.
• Müller, S., …, M. Schmid, …, T. Bieber (2024): Development of a clinical algorithm to predict phenotypic switches between atopic dermatitis and psoriasis (the “Flip-Flop“ phenomenon). Allergy 79 (1), 164-173.
• Huber, H., …, M. Schmid, …, M.-C. Simon (2023): Levels of Alzheimer‘s disease blood biomarkers are altered after food intake – A pilot intervention study in healthy adults. Alzheimer‘s & Dementia 19 (12), 5531-5540.
• Christ, P., …, M. Schmid, B. Sachs (2023): Comparative analysis of information provided in German adverse drug reaction reports sent by physicians, pharmacists and consumers. Drug Safety 46 (12), 1363-1379.
• Monin, M. B., …, M. Schmid, M. A. Gonzalez-Carmona (2023): Deficient immune response following SARS-CoV-2 vaccination in patients with hepatobiliary carcinoma: A forgotten, vulnerable group of patients. Liver Cancer 12 (4), 339-355.
• Maintz, L., …, M. Schmid, T. Bieber (2023): IL-13, periostin and dipeptidyl-peptidase-4 reveal endotype-phenotype associations in atopic dermatitis. Allergy 78 (6), 1554-1569.
• Maintz, L., …, M. Schmid, T. Bieber (2023): Atopic dermatitis: Correlation of distinct risk factors with age of onset in adulthood compared to childhood. Allergy 78 (8), 2181-2201.
• Gregorich, M., …, M. Schmid, …, R. Oberbauer (2023): Development and validation of a prediction model for future estimated glomerular filtration rate in people with type 2 diabetes and chronic kidney disease. JAMA Network Open 6 (4): e231870.
• Dubrall, D., …, M. Schmid, …, J. Bate (2023): Analyses of basal and squamous cell carcinoma reported as an adverse drug reaction and comparison with cases from the cancer registry from Germany. Drugs in R&D 23 (1), 21-33.
• Reinke, C., …, M. Schmid, T. Welchowski (2023): Dementia risk predictions from German claims data using methods of machine learning. Alzheimer’s & Dementia 19 (2), 477-486.
• Jessen, F., …, M. Schmid, …, E. Düzel (2023): Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers. Alzheimer’s & Dementia 19 (2), 487-497.
• Goschzik, T., …, M. Schmid, …, T. Pietsch (2022): Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas. Acta Neuropathologica 144 (6), 1143-1156.
• Jansen, I. E., …, M. Schmid, …, W. van der Flier (2022): Genome-wide meta-analysis for Alzheimer‘s disease cerebrospinal fluid biomarkers. Acta Neuropathologica 144 (5), 821-842.
• Dunbar, H. M. P., …, M. Schmid, …, U. F. O. Luhmann (2022): Repeatability and discriminatory power of chart-based visual function tests in individuals with age-related macular degeneration – a MACUSTAR study report. JAMA Ophthalmology 140 (8), 780-789.
• Schneider, M. P., M. Schmid, …, K.-U. Eckardt (2022): Heart-type fatty acid binding protein, cardiovascular outcomes, and death: Findings from the German CKD cohort study. American Journal of Kidney Diseases 80 (4), 483-494.e1.
• Jacobi, H., …, M. Schmid, T. Klockgether (2022): Evolution of disability in spinocerebellar ataxias type 1, 2, 3, and 6. Annals of Clinical and Translational Neurology 9 (3), 286-295.
• Sachs, B., …, M. Schmid, …, W. Fischer-Barth (2022): Descriptive analysis of 179 German reports of melanoma reported to an adverse drug reaction database as a drug-related adverse effect, and comparison with melanoma cases contained in German cancer registries. Clinical and Experimental Dermatology 47 (6), 1078-1087.
• Sanok, S., …, M. Schmid, …, D. Aeschbach (2022): Road traffic noise impacts sleep continuity in suburban residents: Exposure-response quantification of noise-induced awakenings from vehicle pass-bys at night. Science of The Total Environment 817, Article 152594.
• Bellenguez, C., …, M. Schmid, …, J.-C. Lambert (2022): New insights into the genetic etiology of Alzheimer‘s disease and related dementias. Nature Genetics 54 (4), 412-436.
• Zacharias, H. U., …, M. Schmid, …, P. J. Oefner (2022): A predictive model for progression of CKD to kidney failure based on routine laboratory tests. American Journal of Kidney Diseases 79 (2), 217-230.e1.
• Maintz, L., …, M. Schmid, T. Bieber (2021): Machine learning-based deep phenotyping of atopic dermatitis: Severity-associated factors in adolescent and adult patients. JAMA Dermatology 157 (12), 1414-1424.
• Steinbrenner, I., …, M. Schmid, …, P. Sekula (2021): Urine metabolite levels, adverse kidney outcomes, and mortality in CKD patients: A metabolome-wide association study. American Journal of Kidney Diseases 78 (5), 669-677.
• De Rojas, I., …, M. Schmid, …, A. Ruiz (2021): Common variants in Alzheimer‘s disease and risk stratification by polygenic risk scores. Nature Communications 12:3417.
• Finger, R. P., …, M. Schmid, …, M. Gillies (2020): Lifetime outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration. JAMA Ophthalmology 138 (12), 1234-1240.
• Streeck, H., …, M. Schmid, G. Hartmann (2020): Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany. Nature Communications 11:5829.
• Li, J. Q., …, M. Schmid, …, R. P. Finger (2020): Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysis. British Journal of Ophthalmology 104 (8), 1077-1084.
• Kleineidam, L., …, M. Schmid, …, A. Ramirez (2020): PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathologica 139 (6), 1025-1044.
• Steubl, D., …, M. Schmid, …, J. E. Scherberich (2020): Association of serum uromodulin with death, cardiovascular events, and kidney failure in CKD. Clinical Journal of the American Society of Nephrology 15 (5), 616-624.
• Li, J. Q., …, M. Schmid, …, R. P. Finger (2020): Prevalence, incidence and future projection of diabetic eye disease in Europe: a systematic review and meta-analysis. European Journal of Epidemiology 35 (1), 11-23.
• Scholtes, C., …, M. Schmid, …, G. Calaminus (2019): Health status, health-related quality of life, and socioeconomic outcome in childhood brain tumor survivors: a German cohort study. Neuro-Oncology 21 (8), 1069-1081.
• Schmidt, I. M., …, M. Schmid, …, K.-U. Eckardt (2019): Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study. Clinical Kidney Journal 12 (5), 663-672.
• Li, J. Q., …, M. Schmid, …, R. P. Finger (2019): Incidence of rhegmatogenous retinal detachment in Europe – a systematic review and meta-analysis. Ophthalmologica 242 (2), 81-86.
• Herrlinger, U., …, M. Schmid, …, M. Glas (2019): Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trial. The Lancet 393 (10172), 678-688.
• Oluwagbemigun, …, M. Schmid, …, U. Nöthlings (2019): Developmental trajectories of body mass index from childhood into late adolescence and subsequent late adolescence-young adulthood cardiometabolic risk markers. Cardiovascular Diabetology 18:9.
• Finger, R. P., …, M. Schmid, …, F. G. Holz (2019): MACUSTAR: Development and clinical validation of functional, structural, and patient-reported endpoints in intermediate age-related macular degeneration. Ophthalmologica 241 (2), 61-72.
• Rienks, J., …, M. Schmid, U. Nöthlings (2018): Polyphenol exposure and risk of type 2 diabetes: dose-response meta-analyses and systematic review of prospective cohort studies. The American Journal of Clinical Nutrition 108 (1), 49-61.
• Dubrall, D., M. Schmid, …, B. Sachs (2018): Frequent adverse drug reactions, and medication groups under suspicion – a descriptive analysis based on spontaneous reports to the German Federal Institute for Drugs and Medical Devices from 1978 to 2016. Deutsches Ärzteblatt International 115 (23), 393-400.
• Davies, G., …, M. Schmid, …, I. J. Deary (2018): Study of 300,486 individuals identifies 148 independent genetic loci influencing general cognitive function. Nature Communications 9:2098.
• Schneider, M. P., …, M. Schmid, …, K.-U. Eckardt (2017): Skin sodium concentration correlates with left ventricular hypertrophy in CKD. Journal of the American Society of Nephrology 28 (6), 1867-1876.
• Schneider, M. P., …, M. Schmid, …, K.-U. Eckardt (2015): Implementation of the KDIGO guideline on lipid management requires a substantial increase in statin prescription rates. Kidney International 88 (6), 1411-1418.
• Lindner, M., …, M. Schmid, …, M. Fleckenstein (2015): Directional kinetics of geographic atrophy progression in age-related macular degeneration with foveal sparing. Ophthalmology 122 (7), 1356-1365.
• Titze, S., M. Schmid, …, K.-U. Eckardt (2015): Disease burden and risk profile in referred patients with moderate chronic kidney disease: Composition of the German Chronic Kidney Disease (GCKD) cohort. Nephrology Dialysis Transplantation 30 (3), 441-451.
• Wessel, J. M., …, M. Schmid, …, R. Laemmer (2013): Longitudinal analysis of progression in glaucoma using spectral-domain optical coherence tomography. Investigative Ophthalmology & Visual Science 54 (5), 3613-3620.
• Schmid, A., …, M. Schmid, …, M. Uder (2013): Transvenous renal transplant biopsy via a transfemoral approach. American Journal of Transplantation 13 (5), 1262-1271.
• Eckardt, K.-U., …, M. Schmid, …, S. Titze (2012): The German Chronic Kidney Disease (GCKD) study: Design and methods. Nephrology Dialysis Transplantation 27 (4), 1454-1460.
• Schild, R. L., …, M. Schmid, …, M. E. Hansmann (2008): Weight estimation by three-dimensional ultrasound imaging in the small fetus. Ultrasound in Obstetrics and Gynecology 32 (2), 168-175.